alexa Yoshifumi Saisho | Keio University
ISSN: 2572-5629

Diabetes Case Reports
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Yoshifumi Saisho

Yoshifumi Saisho Yoshifumi Saisho
Department of Internal Medicine
Keio University
Tokyo, Japan

Dr. Saisho received his medical degree in 1998 and his PhD degree in 2009, both from the Keio University School of Medicine in Tokyo. Before obtaining his current position as assistant professor, Dr. Saisho completed a three-year postdoctoral fellowship at the Larry L. Hillblom Islet Research Center at the University of California-Los Angeles’s David Geffen School of Medicine (Prof. Peter C. Butler). Dr. Saisho has served as chief resident in the Department of Internal Medicine at Shizuoka City Shimizu Hospital in Shizuoka and at Hiratsuka Municipal Hospital in Hiratsuka, Japan and was also a clinical fellow in the Division of Nephrology, Endocrinology and Metabolism at Keio University School of Medicine’s Department of Internal Medicine. Dr. Saisho is the author or coauthor of more than 40 publications. He is a member of the Fellows’ Association of the Japanese Society of Internal Medicine, the Fellows’ Association of the Japan Diabetes Society, the Japan Endocrine Society, and the Japan Atherosclerosis Society. Dr. Saisho’s area of interest is Diabetology, especially beta cell dysfunction in diabetes.

Research Interest

1. Cure or reversal of type 1 and type 2 diabetes
2. Islet physiology


Changing Our Mind: Beta Cell Workload Hypothesis
Yoshifumi Saisho
Editorial: Diabetes Case Rep 2016, 1:e101
DOI: 0.4172/2572-5629 .1000 e101
Comparison of Glycemic Control Indicators and Safety Evaluation during Linagliptin Treatment over 6 Months in Japanese Type 2 Diabetic Patients with and without Nephropathy
Masami Tanaka, Takeshi Nishimura, Risa Sekioka, Toshihide Kawai, Shu Meguro, Junichiro Irie, Yoshifumi Saisho and Hiroshi Itoh
Research Article: J Diabetes Metab 2016, 6:648
DOI: 10.4172/2155-6156.1000648
Maternally Inherited Diabetes and Deafness (MIDD) with Undetectable CPeptide Level and Cerebellar Atrophy
Yoshifumi Saisho and Jun Inaishi
Case Report: J Clin Case Rep 2014, 4:366
DOI: 10.4172/2165-7920.1000366
Obesity, Type 2 Diabetes and Beta Cell Failure: An Asian Perspective
Yoshifumi Saisho
Review Article: J Mol Genet Med 2014, S1: 008
DOI: 10.4172/1747-0862.S1-008
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version